DNAi-based therapeutics

Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize DNA Immunotherapy product (VGX-3100) in Greater China
CP Wire
Tue, 03/20/18 - 03:34 pm
Inovio
China
ApolloBio
VGX-3100
DNAi-based therapeutics
HPV
Marina inks $14M discovery pact with ProNAi
Fierce Biotech
Wed, 03/14/12 - 01:01 pm
Marina
ProNai
DNAi-based therapeutics